Cargando…
Evaluating the immunogenicity of gold nanoparticles conjugated RBD with Freund's adjuvant as a potential vaccine against SARS-CoV-2
BACKGROUND: and Introduction: SARS-CoV-2 is currently considered as the most challenging issue in the field of health and medicine by causing a global pandemic. Vaccines are counted as a promising candidate to terminate this deadly pandemic. Various structural proteins in SARS-CoV-2 have recently dr...
Autores principales: | Moshref Javadi, Mahtab, Taghdisi Hosseinzadeh, Mozhgan, Soleimani, Neda, Rommasi, Foad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339102/ https://www.ncbi.nlm.nih.gov/pubmed/35917987 http://dx.doi.org/10.1016/j.micpath.2022.105687 |
Ejemplares similares
-
Liposomal Nanomedicine: Applications for Drug Delivery in Cancer Therapy
por: Rommasi, Foad, et al.
Publicado: (2021) -
Bacterial-Based Methods for Cancer Treatment: What We Know and Where We Are
por: Rommasi, Foad
Publicado: (2021) -
Identification, characterization, and prognosis investigation of pivotal genes shared in different stages of breast cancer
por: Rommasi, Foad
Publicado: (2023) -
Mannosylated T/Tn with Freund’s adjuvant induces cellular
immunity
por: Son, Hye-Youn, et al.
Publicado: (2017) -
Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice
por: Nanishi, Etsuro, et al.
Publicado: (2023)